{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T15:31:33Z","timestamp":1770305493234,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ccm.2025.10.004","type":"journal-article","created":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T23:38:39Z","timestamp":1763336319000},"page":"45-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["When and How Much? Steroids in Sepsis"],"prefix":"10.1016","volume":"47","author":[{"given":"Erica","family":"Crosley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette M.","family":"Esper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ccm.2025.10.004_bib1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"9453","key":"10.1016\/j.ccm.2025.10.004_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0140-6736(04)17667-8","article-title":"Septic shock","volume":"365","author":"Annane","year":"2005","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ccm.2025.10.004_bib3","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/cc2374","article-title":"Clinical review: corticotherapy in sepsis","volume":"8","author":"Prigent","year":"2004","journal-title":"Crit Care"},{"issue":"12","key":"10.1016\/j.ccm.2025.10.004_bib4","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1097\/CCM.0000000000002737","article-title":"Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (part I): society of critical care medicine (SCCM) and European society of intensive care medicine (ESICM) 2017","volume":"45","author":"Annane","year":"2017","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccm.2025.10.004_bib5","doi-asserted-by":"crossref","DOI":"10.1097\/CCE.0000000000001000","article-title":"Corticosteroids in sepsis and septic shock: a systematic review, pairwise, and dose-response meta-analysis","volume":"6","author":"Pitre","year":"2024","journal-title":"Critical Care Explorations"},{"issue":"3","key":"10.1016\/j.ccm.2025.10.004_bib6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1084\/jem.39.3.457","article-title":"The influence of the adrenal glands on resistance : II. The toxic effect of killed bacteria in adrenalectomized rats","volume":"39","author":"Scott","year":"1924","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.ccm.2025.10.004_bib7","first-page":"147","article-title":"The role of corticoids in the management of shock","volume":"49","author":"Schumer","year":"1969","journal-title":"Surg Clin"},{"issue":"20","key":"10.1016\/j.ccm.2025.10.004_bib8","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJM199505183322008","article-title":"The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation","volume":"332","author":"Chrousos","year":"1995","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ccm.2025.10.004_bib9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3949\/ccjm.89gr.22002","article-title":"Steroids in the acutely ill: evolving recommendations and practice","volume":"89","author":"Pastores","year":"2022","journal-title":"Cleve Clin J Med"},{"issue":"2","key":"10.1016\/j.ccm.2025.10.004_bib10","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00003246-200202000-00043","article-title":"The central nervous system hypothalamic-pituitary-adrenal axis in sepsis","volume":"30","author":"Marik","year":"2002","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.ccm.2025.10.004_bib11","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1097\/CCM.0b013e31817603ba","article-title":"Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American college of critical care medicine","volume":"36","author":"Marik","year":"2008","journal-title":"Crit Care Med"},{"issue":"7","key":"10.1016\/j.ccm.2025.10.004_bib12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.5414\/CPP44309","article-title":"Glucocorticoid treatment in patients with septic shock: effects on vasopressor use and mortality","volume":"44","author":"Boyer","year":"2006","journal-title":"Int J Clin Pharmacol Therapeut"},{"issue":"1","key":"10.1016\/j.ccm.2025.10.004_bib13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1073\/pnas.91.1.271","article-title":"Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo","volume":"91","author":"Szab\u00f3","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.ccm.2025.10.004_bib14","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/01.anes.0000286984.39328.96","article-title":"Hydrocortisone preserves the vascular barrier by protecting the endothelial glycocalyx","volume":"107","author":"Chappell","year":"2007","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.ccm.2025.10.004_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa071366","article-title":"Hydrocortisone therapy for patients with septic shock","volume":"358","author":"Sprung","year":"2008","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ccm.2025.10.004_bib16","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1705835","article-title":"Adjunctive glucocorticoid therapy in patients with septic shock","volume":"378","author":"Venkatesh","year":"2018","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ccm.2025.10.004_bib17","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1705716","article-title":"Hydrocortisone plus fludrocortisone for adults with septic shock","volume":"378","author":"Annane","year":"2018","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ccm.2025.10.004_bib18","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.ccm.2025.10.004_bib19","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1097\/CCM.0000000000006172","article-title":"2024 focused update: guidelines on use of corticosteroids in sepsis, acute respiratory distress syndrome, and community-acquired pneumonia","volume":"52","author":"Chaudhuri","year":"2024","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.ccm.2025.10.004_bib20","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2300034","article-title":"Patient-level meta-analysis of low-dose hydrocortisone in adults with septic shock","volume":"2","author":"Pirracchio","year":"2023","journal-title":"NEJM Evid"},{"issue":"5","key":"10.1016\/j.ccm.2025.10.004_bib21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jama.2016.10485","article-title":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial","volume":"316","author":"Gordon","year":"2016","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ccm.2025.10.004_bib22","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00134-018-5197-6","article-title":"Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis","volume":"44","author":"Rygard","year":"2018","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ccm.2025.10.004_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104284","article-title":"The hypothalamus-pituitary-adrenal axis in sepsis- and hyperinflammation-induced critical illness: gaps in current knowledge and future translational research directions","volume":"84","author":"Van den Berghe","year":"2022","journal-title":"EBioMedicine"},{"issue":"16","key":"10.1016\/j.ccm.2025.10.004_bib24","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa1214969","article-title":"Reduced cortisol metabolism during critical illness","volume":"368","author":"Boonen","year":"2013","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ccm.2025.10.004_bib25","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1210\/jc.2005-2089","article-title":"Cortisol response to critical illness: effect of intensive insulin therapy","volume":"91","author":"Vanhorebeek","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ccm.2025.10.004_bib26","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/cid\/cix801","article-title":"Corticosteroids in patients hospitalized with community-acquired pneumonia: systematic review and individual patient data metaanalysis","volume":"66","author":"Briel","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ccm.2025.10.004_bib27","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1097\/CCM.0000000000003021","article-title":"An exploratory reanalysis of the randomized trial on efficacy of corticosteroids as rescue therapy for the late phase of acute respiratory distress syndrome","volume":"46","author":"Meduri","year":"2018","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.ccm.2025.10.004_bib28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ccc.2018.11.005","article-title":"Hydrocortisone in vasodilatory shock","volume":"35","author":"Venkatesh","year":"2019","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.ccm.2025.10.004_bib29","article-title":"Corticosteroid therapy for sepsis: a clinical practice guideline","volume":"362","author":"Lamontagne","year":"2018","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.ccm.2025.10.004_bib30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/cc1498","article-title":"Physiological-dose steroid therapy in sepsis","volume":"6","author":"Yildiz","year":"2002","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.ccm.2025.10.004_bib31","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00000658-197609000-00011","article-title":"Steroids in the treatment of clinical septic shock","volume":"184","author":"Schumer","year":"1976","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.ccm.2025.10.004_bib32","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1177\/0310057X0703500505","article-title":"Gastrointestinal perfusion in septic shock","volume":"35","author":"van Haren","year":"2007","journal-title":"Anaesth Intensive Care"},{"issue":"1","key":"10.1016\/j.ccm.2025.10.004_bib33","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13613-015-0077-5","article-title":"Associations between bolus infusion of hydrocortisone, glycemic variability and insulin infusion rate variability in critically ill patients under moderate glycemic control","volume":"5","author":"van Hooijdonk","year":"2015","journal-title":"Ann Intensive Care"},{"issue":"1","key":"10.1016\/j.ccm.2025.10.004_bib34","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1186\/cc5696","article-title":"Effect of mode of hydrocortisone administration on glycemic control in patients with septic shock: a prospective randomized trial","volume":"11","author":"Loisa","year":"2007","journal-title":"Crit Care"},{"issue":"4","key":"10.1016\/j.ccm.2025.10.004_bib35","first-page":"252","article-title":"Evaluation of hydrocortisone continuous infusion versus intermittent boluses in resolution of septic shock","volume":"42","author":"Hoang","year":"2017","journal-title":"P T"},{"issue":"7","key":"10.1016\/j.ccm.2025.10.004_bib36","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/jama.288.7.862","article-title":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock","volume":"288","author":"Annane","year":"2002","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ccm.2025.10.004_bib37","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/jamainternmed.2023.0258","article-title":"Comparative effectiveness of fludrocortisone and hydrocortisone vs hydrocortisone alone among patients with septic shock","volume":"183","author":"Bosch","year":"2023","journal-title":"JAMA Intern Med"},{"issue":"10","key":"10.1016\/j.ccm.2025.10.004_bib38","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1164\/rccm.202310-1785OC","article-title":"Effectiveness of fludrocortisone plus hydrocortisone versus hydrocortisone alone in septic shock: a systematic review and network meta-analysis of randomized controlled trials","volume":"209","author":"Teja","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.ccm.2025.10.004_bib39","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S2213-2600(19)30417-5","article-title":"Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial","volume":"8","author":"Villar","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"21","key":"10.1016\/j.ccm.2025.10.004_bib40","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1056\/NEJMoa2215145","article-title":"Hydrocortisone in severe community-acquired pneumonia","volume":"388","author":"Dequin","year":"2023","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ccm.2025.10.004_bib41","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1164\/rccm.201806-1197OC","article-title":"Identifying novel sepsis subphenotypes using temperature trajectories","volume":"200","author":"Bhavani","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.ccm.2025.10.004_bib42","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1007\/s00134-022-06890-z","article-title":"Development and validation of novel sepsis subphenotypes using trajectories of vital signs","volume":"48","author":"Bhavani","year":"2022","journal-title":"Intensive Care Med"},{"issue":"20","key":"10.1016\/j.ccm.2025.10.004_bib43","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.2019.5791","article-title":"Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis","volume":"321","author":"Seymour","year":"2019","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.ccm.2025.10.004_bib44","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-2600(14)70097-9","article-title":"Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials","volume":"2","author":"Calfee","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"9","key":"10.1016\/j.ccm.2025.10.004_bib45","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S2213-2600(18)30177-2","article-title":"Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial","volume":"6","author":"Calfee","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"3","key":"10.1016\/j.ccm.2025.10.004_bib46","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1164\/rccm.201603-0645OC","article-title":"Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy","volume":"195","author":"Famous","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.ccm.2025.10.004_bib47","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00003246-199804000-00010","article-title":"Reversal of late septic shock with supraphysiologic doses of hydrocortisone","volume":"26","author":"Bollaert","year":"1998","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.ccm.2025.10.004_bib48","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/jama.2010.2","article-title":"Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial","volume":"303","author":"Annane","year":"2010","journal-title":"JAMA"},{"issue":"17","key":"10.1016\/j.ccm.2025.10.004_bib49","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.2016.14799","article-title":"Effect of hydrocortisone on development of shock among patients with severe sepsis: the HYPRESS randomized clinical trial","volume":"316","author":"Keh","year":"2016","journal-title":"JAMA"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523125000929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523125000929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:56:50Z","timestamp":1770253010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523125000929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0272523125000929"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2025.10.004","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"When and How Much? Steroids in Sepsis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2025.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}